Cleared Special

K102664 - HEMA SCREEN ER

K102664 is an FDA 510(k) clearance for HEMA SCREEN ER, manufactured by Immunostics Inc.,. The device is a Class 2 Hematology device with product code KHE cleared through the Special 510(k) pathway after a 135-day FDA review.

K102664 · Immunostics Inc., · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2011
Decision
135d
Days
Class 2
Risk

K102664 is an FDA 510(k) clearance for the HEMA SCREEN ER. Classified as Reagent, Occult Blood (product code KHE), Class II - Special Controls.

Submitted by Immunostics Inc., (Ocean, US). The FDA issued a Cleared decision on January 28, 2011 after a review of 135 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.6550 - the FDA hematology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Immunostics Inc., devices

FDA 510(k) Submission Details - K102664

510(k) Number K102664 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 15, 2010
Decision Date January 28, 2011
Days to Decision 135 days
Submission Type Special
Review Panel Hematology (HE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d slower than avg
Panel avg: 113d · This submission: 135d
Pathway characteristics
Modification to existing cleared device.

KHE Device Classification - Class 2, Special Controls

Product Code KHE Reagent, Occult Blood
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.6550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - KHE Reagent, Occult Blood

All 68
Devices cleared under the same product code (KHE) and FDA review panel - the closest regulatory comparables to K102664.
OSOM IFOB 25 TEST AND PATIENT COLLECTION KIT OSOM IFOB CONTROL KIT OSOM IFOB 50 TEST KIT
K121397 · SEKISUI Diagnostics, LLC · Dec 2012
IND ONE STEP OCCULT BLOOD (FOB) TEST
K113506 · Ind Diagnostics, Inc. · Dec 2012
FOB ONE STEP RAPID TEST
K110309 · Orient Gene Biotech · Sep 2011
IND ONE STEP FECAL OCCULT BLOOD TEST MODEL 440-10
K100031 · Ind Diagnostic, Inc. · Jul 2010
BIOSIGN IFOBTEST, BIOSIGN FECAL OCCULT BLOOD TEST
K100817 · Princeton BioMeditech Corp. · Jul 2010
HEMOCCULT ICT
K080812 · Beckman Coulter, Inc. · Jun 2008